4.5 Article

The Clinical Picture of Alzheimer's Disease in the Decade Before Diagnosis: Clinical and Biomarker Trajectories

期刊

JOURNAL OF CLINICAL PSYCHIATRY
卷 77, 期 3, 页码 E305-+

出版社

PHYSICIANS POSTGRADUATE PRESS
DOI: 10.4088/JCP.15m09989

关键词

-

资金

  1. Fondation pour la Recherche Medicale
  2. Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale (MGEN), Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante
  3. Regional Government of Aquitaine
  4. Regional Government of Bourgogne
  5. Regional Government of Languedoc-Roussillon
  6. Fondation de France
  7. Ministry of Research-Inserm
  8. Eisai
  9. Fondation Plan Alzheimer
  10. French Agence Nationale de la Recherche (ANR) [06 PNRA 005, 07 LVIE 004, 07 LVIE 003-01]

向作者/读者索取更多资源

Objective: Increasing evidence suggests that Alzheimer's disease begins at least a decade before the diagnosis of dementia. Earlier identification of the disease will have important implications for intervention; however, current models of preclinical changes are theoretical and require verification from empirical observations. Furthermore, these models have not incorporated psychiatric features. Method: Clinical and biological markers were examined at baseline (1999-2001) in 9,076 people aged 65 years and older. A nested case-control study included 830 cases with Alzheimer's disease diagnosed by DSM-IV criteria during the 10-year follow-up and twice as many controls. By taking the distance between baseline and diagnosis as the length of the preclinical period, disease marker trajectories were estimated using nonparametric locally weighted smoothing analysis. Results: Significant differences for the cases compared to the controls were observed on both intercept and slope for truncated amyloid beta(40) (P = .006; P = .003, respectively), C-reactive protein (P = .03; P = .05), verbal fluency (P < .0001; P < .0001), visual recall (P < .0001; P = .007), and hippocampal volume (P = .0002; P = .04) and on the slope only for truncated amyloid beta(42) (P = .01). The cases showed higher levels of depressive symptoms (P = .003), which remained stable over the 10 years to diagnosis. Conclusions: As hypothesized by existing theoretical models, changes in plasma amyloid beta levels, hippocampal atrophy, cognitive loss, and C-reactive protein are already observed up to 10 years before diagnosis. An acceleration in cognitive decline appears to follow a significant increase in amyloid accumulation, and depressive symptomatology remains at a constantly higher level. Overall, clinical and biological markers do not follow the same trajectories; the clinical picture changes according to distance from dementia. (C) Copyright 2016 Physicians Postgraduate Press, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据